| INTRODUC TI ON
Osteoporosis, defined as low bone mineral density (BMD), is a public health concern as it may increase the risk of fractures, morbidity/mortality, and health care costs. 1 It is characterised by the deterioration of the architectural design of bone tissues which reduces bone tissue mass, making the bone become fragile and fracture easily. 2 In addition to the genetic, nutrition, lifestyle, and mechanical factors that determine bone density, environmental exposure to toxic heavy metals such as cadmium (Cd), chromium, and lead also plays a role in osteoporosis.
1 Cadmium toxicity has been reported in several organs including the bone. Cadmium, which has a biologically accumulative effect in the body, occurs traditionally in the environment as a non-essential element used in pigments, coating and stabilizers. [4] [5] [6] [7] It is also used in production of pesticides, galvanising and steel protective plating, rubber processing, batteries, and polyvinyl chloride (PVC) production, 8 and has been listed by the United Nations Environmental Program as a potentially toxic chemical. 9 Cigarette smoking commonly exposes individuals to cadmium as it is naturally found in tobacco leaves, 10 and cadmium has been reported as a major heavy metal carcinogen in humans and animals.
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Most industrial chemicals, including cadmium chloride (CdCl 2 ), cause oxidative stress in the body. 3 Cadmium toxicity is believed to result from the production of reactive oxygen species (ROS) and also from inhibition of cell proliferation and replication of DNA, 12 which may eventually lead to oxidative stress. For many years, researchers have believed that cadmium exposure was most damaging to various visceral organs, 3, 7, [12] [13] [14] and bone loss was secondary. A serious bone disease found in the Jinzu River basin of Japan first hinted that cadmium might cause serious bone loss. Itai-itai disease, which means "ouch, ouch," is a painful result of chronic cadmium poisoning from mining byproducts dumped upstream. 15 These patients had extreme bone demineralization. Clinically significant bone lesions usually occur late in severe chronic cadmium poisoning and include pseudofractures and other effects of osteomalacia and osteoporosis. 16 Cadmium is known to release calcium from bone within hours of exposure 17 and its cytotoxicity depends majorly on distinct ionic mimicry by calcium and zinc substitution, resulting in protein breakdown and ultimately endoplasmic reticulum stress and mitochondrial dilapidation, and eventually cell death. Piliostigma thonningii has a structural formula similar to phosphatidylinositol phosphate, which participates in the insulin signaling pathways that stimulate glucose transport, and is known to possess strong antioxidant activities. 19 It has been observed that D-3-O-methylchiroinositol reduces urinary potency with impaired glucose tolerance, insulin resistance and type 2 diabetes mellitus in rhesus monkeys and human subjects. 20 The challenges in developing novel therapeutic compounds to ameliorate the toxic effects of cadmium exposure on bone led to this research.
| ME THODS

| Extraction and purification of D-3-Omethyl-chiroinositol
D-3-O-methylchiroinositol (D3O) was isolated from the stem bark of Piliostigma thonningii, as described by Asuzu et al.
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The stem bark of the plant was exhaustively extracted with 80% methanol in a Soxhlet extractor at 40°C for 12 hours.
The pure compound was isolated using a column and TLC, lyophilized and stored in the fridge at 4°C until used for the experiments. 
| Chemicals
Cadmium chloride (CdCl 2 ) and Tween20 used for this study were purchased from Sigma-Aldrich Co. (St Louis, MO, USA). All other reagents were of analytical grade. Prior to the experiment, the rats were acclimatised for 7 days with ad libitum feed and water. Afterwards the rats were randomly assigned to 3 groups (n = 12): group A (control) was orally administered 2 mL distilled water); group B was administered 2.5 mg/kg b.w. CdCl 2 in drinking water; 23 group C was administered 2.5 mg/kg b.w. CdCl 2 in drinking water and D-3-O-methyl-chiroinositol (D3O) at 2 mg/kg b.w. daily dissolved in 0.5% Tween20 and administered per os. 19 The experiment lasted for 3 months. Four animals from each group were humanely euthanized at the end of each month under chloroform anaesthesia; the femur, tibia and cervical bones were harvested. Volumetric bone density of the femur and tibia was determined by Archimedes' principle.
| Laboratory animals
After degassing the bone in deionized water, the left femur and tibiae were cut at 2.5 and 2.5 mm, respectively, from the midshaft to obtain a 5-mm-long diaphyseal bone section, which essentially consisted of cortical bone for measurement of bone calcium, phosphate, magnesium, and zinc content. Bone tissues were also obtained from the left tibial bones, the left femoral bones and the cervical bones and were fixed in Bouin's fluid for histological study.
| Bone ash determination
At the end of months 1, 2, and 3, the right femurs and tibiae of selected animal were placed in a muffle furnace at 700°C for 20-24 hours. Crucibles were cooled in a 100°C oven for 60 minutes before weighing with a sensitive Shimadzu ® digital electronic weighing balance (Model BR9010; Guangdong, China).
| Measurement of bone calcium, phosphate, magnesium, and zinc
The 5 mm left femoral and tibial bones tissues obtained were used for measurement of calcium, phosphate, magnesium, and zinc content. After washing with ethanol, each 5-mm piece of tibial diaphysis was dried at 60°C for 1 hour and weighed.
Then, 5 mL of hydrochloric acid and 3 mL of nitric acid were added, dissociation by heating was performed with a sand burst, and the mixture was dissolved in 50 mL of purified water.
Next, a 10-fold dilution was performed and 3 standard solu- 
| Chemical analyses
Following biomechanical assessment, pieces of bones from the left femur of all groups in the experiment were demarrowed with cold 0.25 mol/L sucrose, pulverized in liquid nitrogen, lyophilized, and diluted in 6 mol/L HCl (1:5 wt:vol), then analyzed colorimetrically for hydroxyproline using Ehrlich's reagent.
| Histological examination
The femur, tibia and cervical bones fixed in Bouin's fluid were decal- 
| Biochemical analysis
Cadmium concentrations in the bones were determined using the femur, tibia, and cervical bones. Briefly, samples of the bones obtained at the end of months 1, 2, and 3 of the experiment were dried to a constant weight. Then they were digested in concentrated nitric acid. Once the digestion was complete, the samples were cooled at room temperature and brought to a constant volume (5 mL) by adding deionized water. For cadmium determination, an atomic absorption spectrophotometer (Perkin-Elmer Analyst 100) was used.
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| Data analysis
The mixed design ANOVA model was used to determine significant differences in mean bone density and serum concentration of normal, negative and D-3-O-methyl-chiroinositol (D3O) ameliorated groups at months 1, 2, and 3, respectively. The Greenhouse-Geisser adjustment was reported where Mauchley's test of sphericity failed; assumption of sphericity, and main effects were compared with Bonferroni adjustment. Values of P < 0.05 were considered significant.
| RE SULTS
There were statistically significant differences (P ≤ 0.05) in the weights of the tibial, cervical and femoral bones in all groups (Figures 1-3 The repeated measures ANOVA test revealed that the tib- Histopathology of the tibial, cervical, and femoral bones of Wistar rats treated with D3O showed bone trabeculae and viable osteocytes.
The CdCl 2 -treated group showed necrotic and severely hypertrophied osteocytes and there was significant proliferation of blood vessels in the CdCl 2 -treated group, showing attempts at revascularisation and repair (Figures 4-9 ). Lacunae counts showed significant variation within groups and across the groups with time ( Figure 10 ).
| D ISCUSS I ON
The results of this study demonstrated that cadmium can act directly on bone cells in the bone organ to decrease bone formation and increase bone resorption. These results strongly support the hypothesis that cadmium, at low levels of exposure, can act directly on bone cells, in the absence of other effects, to cause osteoporosis. A study reported that even low heavy metal concentrations can increase the risk of osteoporosis. 25 Another study 17 also reported that higher cadmium concentrations led to lower bone densities.
However, the mechanism involving the association between heavy metals and bone damage has not been fully explained, although there have been reports that kidney damage is an important pathway for bone loss, and that subsequent calcium malabsorption and iron deficiency in the body increases heavy metal absorption, which, if prolonged, causes proteinuria and consequent bone lesions.
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It has, however, been established that cadmium causes osteoclast activation, 26 which results in replacement of the calcium in hydroxyapatite. 25, 27 This reduces the strength of the bone by interfering with collagen production in the bone. 28, 29 It also increases the urinary calcium excretion, 30,31 thereby leading to osteoporosis. can be replaced with cadmium in hydroxyapatite to reduce its strength. Cadmium may also interfere with collagen production in the bone 28, 29 and increase urinary calcium excretion.
30,31
Fibroblast growth factor 23 (FGF23) is a bone-derived phosphaturic factor and is known to regulate blood inorganic phosphate (Pi).
Cadmium, a toxic transition metal, which is widely used in industry, affects human health through occupational and environmental exposure. Phosphaturia has been documented following cadmium exposure in both human and experimental animals. In this study there were significant changes in serum phosphorus concentration in the treated group compared to the control. In a previous animal study, cadmium administration increased serum FGF23 concentrations.
Moreover, medication such as infusion of selected iron-containing compounds increases serum FGF23 concentrations, with patients developing hypophosphatemia. Thus, a relationship between the metal ions (Cd and Fe) and the FGF23 metabolic pathway was proposed. 
| CON CLUS ION
The authors conclude that D-3-O-methyl-chiroinositol extract from
Piliostigma thionningii stem bark ameliorated cadmium chlorideinduced osteoporosis in male Wistar rats, possibly by downregulation of osteoclastogenesis.
ACK N OWLED G EM ENTS
The authors wish to acknowledge Professor Isaac Uzoma Asuzu for help with the extraction of D3O.
CO N FLI C T O F I NTE R E S T
None.
AUTH O R CO NTR I B UTI O N S
EAU and CON designed the study, EAU, CON, CNA did the experimental research, EAU, CON and TON wrote the initial manuscript, 
Lacuna count
Control Cd Cd + D30
EAO and OBO did the data analysis and interpretations and EAU, CNA and OKE performed the histological study. All authors proofread every submission.
O RCI D
Edwin Aihanuwa Uwagie-Ero https://orcid.org/0000-0001-6945-2169
